Julie Sunderland
QuietNamed in filings at Biomatics Capital PartnersOn the current fund
- Board seats filed
Named in filings at Biomatics Capital PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Variant Bio | Biotech & pharma | July 2020 | Dimension Capital, Lux Capital |
| Compass Therapeutics | Biotech & pharma | June 2020 | 270 Healthcare Growth, Borealis, Caduceus Capital, Orbimed Genesis |
| Guide Therapeutics | Medical devices | February 2019 | Greatpoint Ventures Innovation |
| eGenesis | Biotech & pharma | March 2017 | Aditum Bio, ARCH Venture Partners, Kendall Capital Partners |
| Aledade | Healthcare services | December 2016 | NaviMed Partners |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Julie Sunderland on the board, based on 5 filed seats with a verified or cited source.